Matches in SemOpenAlex for { <https://semopenalex.org/work/W3090351609> ?p ?o ?g. }
- W3090351609 abstract "Summary SARS-CoV-2 infection causes an inflammatory cytokine storm and acute lung injury. Currently there are no effective antiviral and/or anti-inflammatory therapies. Here we demonstrate that 2019 SARS-CoV-2 spike protein subunit 1 (CoV2-S1) induces high levels of NF-κB activations, production of pro-inflammatory cytokines and mild epithelial damage, in human bronchial epithelial cells. CoV2-S1-induced NF-κB activation requires S1 interaction with human ACE2 receptor and early activation of endoplasmic reticulum (ER) stress, and associated unfolded protein response (UPR), and MAP kinase signalling pathways. We developed an antagonistic peptide that inhibits S1-ACE2 interaction and CoV2-S1-induced productions of pro-inflammatory cytokines. The existing FDA-approved ER stress inhibitor, 4-phenylburic acid (4-PBA), and MAP kinase inhibitors, trametinib and ulixertinib, ameliorated CoV2-S1-induced inflammation and epithelial damage. These novel data highlight the potentials of peptide-based antivirals for novel ACE2-utilising CoVs, while repurposing existing drugs may be used as treatments to dampen elevated inflammation and lung injury mediated by SARS-CoV-2." @default.
- W3090351609 created "2020-10-08" @default.
- W3090351609 creator A5002661071 @default.
- W3090351609 creator A5005347385 @default.
- W3090351609 creator A5014911160 @default.
- W3090351609 creator A5015543605 @default.
- W3090351609 creator A5020422022 @default.
- W3090351609 creator A5024850318 @default.
- W3090351609 creator A5026882361 @default.
- W3090351609 creator A5055421170 @default.
- W3090351609 creator A5065602013 @default.
- W3090351609 creator A5072353038 @default.
- W3090351609 creator A5086600671 @default.
- W3090351609 date "2020-10-01" @default.
- W3090351609 modified "2023-10-01" @default.
- W3090351609 title "SARS-CoV-2 Spike protein promotes hyper-inflammatory response that can be ameliorated by Spike-antagonistic peptide and FDA-approved ER stress and MAP kinase inhibitors <i>in vitro</i>" @default.
- W3090351609 cites W1488281450 @default.
- W3090351609 cites W1543336029 @default.
- W3090351609 cites W1697178647 @default.
- W3090351609 cites W1932202918 @default.
- W3090351609 cites W1967441216 @default.
- W3090351609 cites W1969929211 @default.
- W3090351609 cites W1982533785 @default.
- W3090351609 cites W1991999080 @default.
- W3090351609 cites W1994391392 @default.
- W3090351609 cites W1999644843 @default.
- W3090351609 cites W2013924448 @default.
- W3090351609 cites W2023095097 @default.
- W3090351609 cites W2029495947 @default.
- W3090351609 cites W2036285327 @default.
- W3090351609 cites W2044973755 @default.
- W3090351609 cites W2048456744 @default.
- W3090351609 cites W2067171867 @default.
- W3090351609 cites W2076361525 @default.
- W3090351609 cites W2080901528 @default.
- W3090351609 cites W2085410427 @default.
- W3090351609 cites W2085635715 @default.
- W3090351609 cites W2090290516 @default.
- W3090351609 cites W2102388558 @default.
- W3090351609 cites W2111452369 @default.
- W3090351609 cites W2116776033 @default.
- W3090351609 cites W2125543887 @default.
- W3090351609 cites W2128975348 @default.
- W3090351609 cites W2130318026 @default.
- W3090351609 cites W2142321394 @default.
- W3090351609 cites W2146934968 @default.
- W3090351609 cites W2169857299 @default.
- W3090351609 cites W2267715084 @default.
- W3090351609 cites W2439973029 @default.
- W3090351609 cites W2588729022 @default.
- W3090351609 cites W2604137520 @default.
- W3090351609 cites W2751285788 @default.
- W3090351609 cites W2774483419 @default.
- W3090351609 cites W2792478764 @default.
- W3090351609 cites W2955030790 @default.
- W3090351609 cites W2963945351 @default.
- W3090351609 cites W2964122509 @default.
- W3090351609 cites W2969282322 @default.
- W3090351609 cites W2990414093 @default.
- W3090351609 cites W3000186698 @default.
- W3090351609 cites W3001118548 @default.
- W3090351609 cites W3004280078 @default.
- W3090351609 cites W3011398105 @default.
- W3090351609 cites W3012421327 @default.
- W3090351609 cites W3014663601 @default.
- W3090351609 cites W3015190630 @default.
- W3090351609 cites W3016237970 @default.
- W3090351609 cites W3033884900 @default.
- W3090351609 cites W3198161415 @default.
- W3090351609 doi "https://doi.org/10.1101/2020.09.30.317818" @default.
- W3090351609 hasPublicationYear "2020" @default.
- W3090351609 type Work @default.
- W3090351609 sameAs 3090351609 @default.
- W3090351609 citedByCount "21" @default.
- W3090351609 countsByYear W30903516092020 @default.
- W3090351609 countsByYear W30903516092021 @default.
- W3090351609 countsByYear W30903516092022 @default.
- W3090351609 countsByYear W30903516092023 @default.
- W3090351609 crossrefType "posted-content" @default.
- W3090351609 hasAuthorship W3090351609A5002661071 @default.
- W3090351609 hasAuthorship W3090351609A5005347385 @default.
- W3090351609 hasAuthorship W3090351609A5014911160 @default.
- W3090351609 hasAuthorship W3090351609A5015543605 @default.
- W3090351609 hasAuthorship W3090351609A5020422022 @default.
- W3090351609 hasAuthorship W3090351609A5024850318 @default.
- W3090351609 hasAuthorship W3090351609A5026882361 @default.
- W3090351609 hasAuthorship W3090351609A5055421170 @default.
- W3090351609 hasAuthorship W3090351609A5065602013 @default.
- W3090351609 hasAuthorship W3090351609A5072353038 @default.
- W3090351609 hasAuthorship W3090351609A5086600671 @default.
- W3090351609 hasBestOaLocation W30903516091 @default.
- W3090351609 hasConcept C126322002 @default.
- W3090351609 hasConcept C139447449 @default.
- W3090351609 hasConcept C158617107 @default.
- W3090351609 hasConcept C184235292 @default.
- W3090351609 hasConcept C203014093 @default.
- W3090351609 hasConcept C2776914184 @default.
- W3090351609 hasConcept C2778472372 @default.
- W3090351609 hasConcept C2779134260 @default.
- W3090351609 hasConcept C2779281246 @default.